Prevalence of, and Risk Factors for, Chronic Idiopathic Constipation in the Community: Systematic Review and Meta-analysis
2011/05/24 by Nicole C Suares, Alexander C Ford, Alexander C. Ford · 28 citations
Medicine · #Gastrointestinal motility and disorders #Congenital gastrointestinal and neural anomalies #Gastroesophageal reflux and treatments
paper · doi:10.1038/ajg.2011.164
Abstract
OBJECTIVES: Chronic idiopathic constipation (CIC) is a common functional gastrointestinal disorder in the community, yet no previous systematic review and meta-analysis has estimated the global prevalence, or potential risk factors for the condition. METHODS: MEDLINE, EMBASE, and EMBASE Classic were searched (up to December 2010) to identify population-based studies reporting the prevalence of CIC in adults (≥15 years), according to self-report, questionnaire, or specific symptom-based criteria. The prevalence of CIC was extracted for all studies, and according to country, age, gender, socioeconomic status, and presence or absence of irritable bowel syndrome (IBS) where reported. Pooled prevalence overall, and according to study location and certain other characteristics, as well as odds ratios (ORs), with 95% confidence intervals (CIs) were calculated. RESULTS: Of the 100 papers evaluated, 45 reported the prevalence of CIC in 41 separate study populations, containing 261,040 subjects. Pooled prevalence of CIC in all studies was 14% (95% CI: 12-17%). The prevalence of CIC was lower in South East Asian studies, and in studies using the Rome II or III criteria. The prevalence of CIC was higher in women (OR: 2.22; 95% CI: 1.87-2.62), and increased with age and lower socioeconomic status. The prevalence was markedly higher in subjects who also reported IBS (OR: 7.98; 95% CI: 4.58-13.92), suggesting common pathogenic mechanisms. CONCLUSIONS: Pooled prevalence of CIC in the community was 14%, and of similar magnitude in most geographical regions. Rates were higher in women, older individuals, and those of lower socioeconomic status. Presence of IBS was strongly associated with CIC.
Cited by
- Global prevalence of constipation in older adults: a systematic review and meta-analysis
- Meta-analysis of randomized controlled trials of the effects of probiotics on functional constipation in adults
- CARD14 signaling in intestinal epithelial cells induces intestinal inflammation and intestinal transit delay
- Regional colon transit in patients with dys-synergic defaecation or slow transit in patients with constipation. [europepmc]
- Association of low dietary intake of fiber and liquids with constipation: evidence from the National Health and Nutrition Examination Survey. [europepmc]
- Alteration of gut microbiota and efficacy of probiotics in functional constipation. [europepmc]
- Meta-analyses on prevalence of selected Parkinson's nonmotor symptoms before and after diagnosis. [europepmc]
- Diagnostic accuracy study of anorectal manometry for diagnosis of dyssynergic defecation. [europepmc]
- Guidelines for the Diagnosis and Treatment of Chronic Functional Constipation in Korea, 2015 Revised Edition. [europepmc]
- Diagnosis and Treatment of Dyssynergic Defecation. [europepmc]
- Chronic constipation diagnosis and treatment evaluation: the "CHRO.CO.DI.T.E." study. [europepmc]
- Prediction of Delayed Colonic Transit Using Bristol Stool Form and Stool Frequency in Eastern Constipated Patients: A Difference From the West. [europepmc]
- Determining an optimal clinical dose of elobixibat, a novel inhibitor of the ileal bile acid transporter, in Japanese patients with chronic constipation: a phase II, multicenter, double-blind, placebo-controlled randomized clinical trial. [europepmc]
- Unveiling the gut microbiota composition and functionality associated with constipation through metagenomic analyses. [europepmc]
- The Better Understanding and Recognition of the Disconnects, Experiences, and Needs of Patients with Chronic Idiopathic Constipation (BURDEN-CIC) Study: Results of an Online Questionnaire. [europepmc]
- Randomized clinical trial: efficacy and safety of plecanatide in the treatment of chronic idiopathic constipation. [europepmc]
- Effects of 28-day Bifidobacterium animalis subsp. lactis HN019 supplementation on colonic transit time and gastrointestinal symptoms in adults with functional constipation: A double-blind, randomized, placebo-controlled, and dose-ranging trial. [europepmc]
- Prevalence of Chronic Constipation and Its Associated Factors in Pars Cohort Study: A Study of 9000 Adults in Southern Iran. [europepmc]
- Indian consensus on chronic constipation in adults: A joint position statement of the Indian Motility and Functional Diseases Association and the Indian Society of Gastroenterology. [europepmc]
- Defining constipation to estimate its prevalence in the community: results from a national survey. [europepmc]
- Impact of a probiotic product on bowel habits and microbial profile in participants with functional constipation: A randomized controlled trial. [europepmc]
- Chronic Constipation in the United States: Results From a Population-Based Survey Assessing Healthcare Seeking and Use of Pharmacotherapy. [europepmc]
- The Humanistic and Economic Burden of Chronic Idiopathic Constipation in the USA: A Systematic Literature Review. [europepmc]
- Potential risk factors for constipation in the community. [europepmc]
- Chronic Constipation: Is a Nutritional Approach Reasonable? [europepmc]
- Role of gut microbiota in functional constipation. [europepmc]
- Usefulness of Bifidobacterium longum BB536 in Elderly Individuals With Chronic Constipation: A Randomized Controlled Trial. [europepmc]
- Probiotics, prebiotics, and synbiotics in chronic constipation: Outstanding aspects to be considered for the current evidence. [europepmc]
Related